Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Hopkins

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|January 24, 2003
Helicobacter pyloriJoette M Meyer, Robert J Hopkins
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2004
Clinical efficacy of intramuscular vaccinia immune globulin: a literature reviewRobert J Hopkins, J Michael Lane
Expert Review of Vaccines|October 30, 2016
Licensure strategy for pre- and post-exposure prophylaxis of biothrax vaccine: the first vaccine licensed using the FDA animal ruleJanice Longstreth, Mario H Skiadopoulos, Robert J Hopkins
Archives of Internal Medicine|January 16, 2008
Preattack vaccination against anthrax may be cost-effective in certain populationsRobert J Hopkins, Thomas A Waytes, Thomas K Zink
Proceedings of the National Academy of Sciences of the United States of America|February 14, 2002
A liposome-based therapeutic vaccine against beta -amyloid plaques on the pancreas of transgenic NORBA miceClaude Nicolau, Ruth Greferath, Teodor Silviu Balaban, et al.
Jac-Antimicrobial Resistance|May 9, 2022
Combination of phage therapy and cefiderocol to successfully treat <i>Pseudomonas aeruginosa</i> cranial osteomyelitisPatricia J Simner, Jerald Cherian, Gina A Suh, et al.
Vaccine|May 25, 2013
Randomized, double-blind, placebo-controlled, safety and immunogenicity study of 4 formulations of Anthrax Vaccine Adsorbed plus CPG 7909 (AV7909) in healthy adult volunteersRobert J Hopkins, Nancy F Daczkowski, Paulina E Kaptur, et al.
Vaccine|March 12, 2014
Phase 3 trial evaluating the immunogenicity and safety of a three-dose BioThrax® regimen for post-exposure prophylaxis in healthy adultsRobert J Hopkins, Cris Howard, Ericka Hunter-Stitt, et al.
Vaccine|March 17, 2016
Randomized, double-blind, active-controlled study evaluating the safety and immunogenicity of three vaccination schedules and two dose levels of AV7909 vaccine for anthrax post-exposure prophylaxis in healthy adultsRobert J Hopkins, Gurdyal Kalsi, Victor M Montalvo-Lugo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2004
Safety and pharmacokinetic evaluation of intravenous vaccinia immune globulin in healthy volunteersRobert J Hopkins, William G Kramer, William C Blackwelder, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|January 24, 2003
Helicobacter pyloriJoette M Meyer, Robert J Hopkins
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2004
Clinical efficacy of intramuscular vaccinia immune globulin: a literature reviewRobert J Hopkins, J Michael Lane
Expert Review of Vaccines|October 30, 2016
Licensure strategy for pre- and post-exposure prophylaxis of biothrax vaccine: the first vaccine licensed using the FDA animal ruleJanice Longstreth, Mario H Skiadopoulos, Robert J Hopkins
Archives of Internal Medicine|January 16, 2008
Preattack vaccination against anthrax may be cost-effective in certain populationsRobert J Hopkins, Thomas A Waytes, Thomas K Zink
Proceedings of the National Academy of Sciences of the United States of America|February 14, 2002
A liposome-based therapeutic vaccine against beta -amyloid plaques on the pancreas of transgenic NORBA miceClaude Nicolau, Ruth Greferath, Teodor Silviu Balaban, et al.
Jac-Antimicrobial Resistance|May 9, 2022
Combination of phage therapy and cefiderocol to successfully treat <i>Pseudomonas aeruginosa</i> cranial osteomyelitisPatricia J Simner, Jerald Cherian, Gina A Suh, et al.
Vaccine|May 25, 2013
Randomized, double-blind, placebo-controlled, safety and immunogenicity study of 4 formulations of Anthrax Vaccine Adsorbed plus CPG 7909 (AV7909) in healthy adult volunteersRobert J Hopkins, Nancy F Daczkowski, Paulina E Kaptur, et al.
Vaccine|March 12, 2014
Phase 3 trial evaluating the immunogenicity and safety of a three-dose BioThrax® regimen for post-exposure prophylaxis in healthy adultsRobert J Hopkins, Cris Howard, Ericka Hunter-Stitt, et al.
Vaccine|March 17, 2016
Randomized, double-blind, active-controlled study evaluating the safety and immunogenicity of three vaccination schedules and two dose levels of AV7909 vaccine for anthrax post-exposure prophylaxis in healthy adultsRobert J Hopkins, Gurdyal Kalsi, Victor M Montalvo-Lugo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2004
Safety and pharmacokinetic evaluation of intravenous vaccinia immune globulin in healthy volunteersRobert J Hopkins, William G Kramer, William C Blackwelder, et al.
Pageof 2